Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.45 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.45 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.40 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.35 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.34 |
| ▸ | DUT | P33316 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27782735 | 0.99 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| Phosphoric Acid SCHEMBL27944541 | 0.95 | P2RY6 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| Phosphoric Acid SCHEMBL7594885 | 0.95 | P2RY6 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL30388810 | 0.93 | P2RY6 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL4952061 | 0.90 | SLC28A1 (0.38) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL29783611 | 0.90 | P2RY6 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| Triphosphate SCHEMBL27901431 | 0.89 | P2RY6 (0.53) | P2RY6P2RY2P2RY4 | |
| SCHEMBL6851760 | 0.89 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| Fluorouracil SCHEMBL16835735 | 0.88 | LMNA (0.38) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL28786348 | 0.85 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10678 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570704-B2 | Functionally modified maytansinoids and compositions and methods of use thereof | University of Georgie Research Foundation, Inc. (US) | 2026-03-10 | — | — | US | claimed |
| US-20250268993-A1 | ALKALINE PHOSPHATE-BASED ONCOLOGY TREATMENTS | THERIVA BIOLOGICS, INC. | 2025-08-28 | — | — | US | claimed |
| CN-120138086-A | Process for preparing nucleoside analogues | 正大天晴药业集团股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-12318434-B2 | Alkaline phosphate-based oncology treatments | THERIVA BIOLOGICS, INC. (US) | 2025-06-03 | — | — | US | claimed |
| EP-4558641-A1 | METHODS FOR DETECTION AND REDUCTION OF SAMPLE PREPARATION-INDUCED METHYLATION ARTIFACTS | Guardant Health, Inc. (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119923475-A | Method for detecting and reducing sample preparation induced methylation artifacts | 夸登特健康公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119838022-A | Amatoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| US-20250116671-A1 | Kinase Activity In Tumors | INSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER (US) | 2025-04-10 | — | — | US | claimed |
| CN-119638766-A | Method for separating and purifying fluoronucleoside | 中国科学院青岛生物能源与过程研究所 | 2025-03-18 | — | — | CN | claimed |
| CN-119630427-A | Anti-FGFR 3 antibody conjugates and medical uses thereof | 启德医药科技（苏州）有限公司 | 2025-03-14 | — | — | CN | claimed |
| WO-1991017660-A1 | 5,10-METHYLENE-TETRAHYDROFOLATE AS A MODULATOR OF A CHEMOTHERAPEUTIC AGENT | SPEARS COLIN P (US) | 1991-11-28 | — | — | WO | claimed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | claimed |
| EP-0352988-A2 | Polynucleotide probes for horses | HER MAJESTY THE QUEEN IN RIGHT OF NEW ZEALAND (NZ) | 1990-01-31 | — | — | EP | claimed |
| CN-88102026-A | CHEMO-RADIO-IMMUNO-CONJUGATES | — | 1988-09-28 | — | — | CN | claimed |
| EP-0282057-A2 | Chemo-radio-immuno-conjugates | THE BOARD OF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1988-09-14 | — | — | EP | claimed |
| US-4585736-A | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-04-29 | — | — | US | claimed |
| US-4416875-A | ANTITUMOR AGENTS | FUNAI YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1983-11-22 | — | — | US | claimed |
| EP-0038357-A4 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS. | UNIV ILLINOIS (US) | 1982-03-22 | — | — | EP | claimed |
| EP-0038357-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | University of Illinois Foundation (US) | 1981-10-28 | — | — | EP | claimed |
| WO-1981001145-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | UNIV ILLINOIS (US) | 1981-04-30 | — | — | WO | claimed |